(NASDAQ: LIVN) Livanova's forecast annual revenue growth rate of 4.67% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.82%.
Livanova's revenue in 2025 is $1,275,380,000.On average, 3 Wall Street analysts forecast LIVN's revenue for 2025 to be $71,799,429,909, with the lowest LIVN revenue forecast at $70,479,908,187, and the highest LIVN revenue forecast at $72,502,811,323. On average, 3 Wall Street analysts forecast LIVN's revenue for 2026 to be $76,277,788,488, with the lowest LIVN revenue forecast at $75,692,564,246, and the highest LIVN revenue forecast at $76,853,961,465.
In 2027, LIVN is forecast to generate $80,452,657,071 in revenue, with the lowest revenue forecast at $79,389,406,096 and the highest revenue forecast at $81,515,908,045.